JPH0572384B2 - - Google Patents

Info

Publication number
JPH0572384B2
JPH0572384B2 JP61093477A JP9347786A JPH0572384B2 JP H0572384 B2 JPH0572384 B2 JP H0572384B2 JP 61093477 A JP61093477 A JP 61093477A JP 9347786 A JP9347786 A JP 9347786A JP H0572384 B2 JPH0572384 B2 JP H0572384B2
Authority
JP
Japan
Prior art keywords
formula
compound
carbon atoms
hydrogen
substituent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61093477A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6236370A (ja
Inventor
Buraun Deuitsuto
Ian Daueru Robaato
Buraian Haaguriiusu Rodonii
Jefurii Mein Buraian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of JPS6236370A publication Critical patent/JPS6236370A/ja
Publication of JPH0572384B2 publication Critical patent/JPH0572384B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C07D273/02—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
    • C07D273/04—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/194—Radicals derived from thio- or thiono carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
JP61093477A 1980-11-14 1986-04-24 チアジアジニル誘導体及びその製法 Granted JPS6236370A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8036680 1980-11-14
GB8036680 1980-11-14

Publications (2)

Publication Number Publication Date
JPS6236370A JPS6236370A (ja) 1987-02-17
JPH0572384B2 true JPH0572384B2 (en]) 1993-10-12

Family

ID=10517317

Family Applications (3)

Application Number Title Priority Date Filing Date
JP56181250A Pending JPS57109771A (en) 1980-11-14 1981-11-13 Heterocyclic compound, manufacture and pharmaceutical composition for treating acute or chronic heart disease
JP61093476A Pending JPS6230771A (ja) 1980-11-14 1986-04-24 オキサジアジニル誘導体及びその製法
JP61093477A Granted JPS6236370A (ja) 1980-11-14 1986-04-24 チアジアジニル誘導体及びその製法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP56181250A Pending JPS57109771A (en) 1980-11-14 1981-11-13 Heterocyclic compound, manufacture and pharmaceutical composition for treating acute or chronic heart disease
JP61093476A Pending JPS6230771A (ja) 1980-11-14 1986-04-24 オキサジアジニル誘導体及びその製法

Country Status (20)

Country Link
US (4) US4423045A (en])
EP (1) EP0052442B1 (en])
JP (3) JPS57109771A (en])
KR (1) KR830007624A (en])
AU (1) AU7709181A (en])
CA (1) CA1176250A (en])
DD (1) DD202020A5 (en])
DE (1) DE3172252D1 (en])
DK (1) DK498881A (en])
ES (2) ES8307231A1 (en])
FI (1) FI813566L (en])
GR (1) GR79554B (en])
HU (1) HU185979B (en])
MW (1) MW4881A1 (en])
NO (1) NO813850L (en])
NZ (1) NZ198967A (en])
PL (2) PL238802A1 (en])
PT (1) PT73995B (en])
ZA (1) ZA817597B (en])
ZW (1) ZW26381A1 (en])

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4616014A (en) * 1981-10-22 1986-10-07 Fujisawa Pharmaceutical Co., Ltd. Triazine derivatives, and pharmaceutical compositions comprising the same
US4495185A (en) * 1981-11-12 1985-01-22 Imperial Chemical Industries, Plc 1,2,4-Triazin-3(2H) ones
ZA827641B (en) * 1981-11-12 1983-09-28 Ici Plc Thiadiazine, oxadiazine and triazine derivatives which possess cardiotonic and/or antihypertensive activity
CA1199027A (en) * 1981-11-12 1986-01-07 Stuart D. Mills Heterocyclic derivatives of pyridazinone, thiadiazinone, oxadiazinone and triazinone
US4657906A (en) * 1982-06-05 1987-04-14 Smith Kline & French Laboratories Ltd. Heterocyclic compounds having inotropic activity
JPS5962578A (ja) * 1982-10-04 1984-04-10 Mitsui Toatsu Chem Inc オキサジアジン誘導体およびそれを含有する医薬組成物
US4581356A (en) * 1983-03-22 1986-04-08 Fujisawa Pharmaceutical Co., Ltd. Triazine derivatives, and pharmaceutical compositions comprising the same
GB8310435D0 (en) * 1983-04-18 1983-05-25 Fujisawa Pharmaceutical Co Triazine derivatives
JPS59196874A (ja) * 1983-04-22 1984-11-08 Fujisawa Pharmaceut Co Ltd トリアジン誘導体
GB8328907D0 (en) * 1983-10-28 1983-11-30 Smith Kline French Lab Chemical compounds
GB8329784D0 (en) * 1983-11-08 1983-12-14 Smith Kline French Lab Heterocyclic compounds
GB8332313D0 (en) * 1983-12-02 1984-01-11 Smith Kline French Lab Chemical compounds
US4508718A (en) * 1984-01-16 1985-04-02 Warner-Lambert Company Cardiotonic and antihypertensive oxadiazinone compounds
WO1986002074A1 (en) 1984-10-04 1986-04-10 Zenyaku Kogyo Kabushiki Kaisha Novel 1,4-thiazine derivatives, process for their preparation, and cardiotonics containing the same
JPS61106574A (ja) * 1984-10-29 1986-05-24 Yoshitomi Pharmaceut Ind Ltd オキサ（またはチア）ジアジン誘導体
DE3531658A1 (de) * 1985-09-05 1987-03-12 Boehringer Mannheim Gmbh Heterocyclisch substituierte indole, zwischenprodukte, verfahren zu ihrer herstellung und arzneimittel
FR2592878B1 (fr) * 1986-01-16 1988-12-16 Pf Medicament Monoaryl-5 as triazinones-3 substituees en position 2, leur procede de preparation et leur application en tant que medicaments
US4898862A (en) * 1986-03-20 1990-02-06 Sankyo Company Limited 1,2,4-triazinone derivatives, their preparation and use
US4861773A (en) * 1986-04-28 1989-08-29 Smith Kline & French Laboratories Limited Heterocyclic compounds
GB8610369D0 (en) * 1986-04-28 1986-06-04 Smith Kline French Lab Heterocyclic compounds
DE3706427A1 (de) * 1987-02-27 1988-09-08 Boehringer Mannheim Gmbh Neue substituierte 3h-indole, zwischenprodukte, verfahren zu ihrer herstellung sowie arzneimittel
AU614965B2 (en) * 1987-06-06 1991-09-19 Merck Patent Gesellschaft Mit Beschrankter Haftung Thiadiazinones
GB8903130D0 (en) 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
US5185332A (en) * 1989-02-11 1993-02-09 Orion-Yhtyma Oy Thiadiazines and pharmaceutical compositions thereof as well as method of use
DE3913597A1 (de) * 1989-04-25 1990-11-08 Heumann Pharma Gmbh & Co Diazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE4239540A1 (de) * 1992-11-25 1994-05-26 Asta Medica Ag Neue heterocyclische Verbindungen mit antiasthmatischer/antiallergischer, entzündungshemmender, positiv inotroper und blutdrucksenkender Wirkung
TW309520B (en]) * 1994-04-26 1997-07-01 Mitsubishi Chem Corp
PL182505B1 (pl) 1994-05-04 2002-01-31 Bayer Aktiengesellschaf Podstawione amidy aromatycznych kwasów tiokarboksylowych, sposób wytwarzania tych związków, sposób zwalczania niepożądanych roślin i środki chwastobójcze
USRE39263E1 (en) * 1994-05-04 2006-09-05 Bayer Aktiengesellschaft Substituted aromatic thiocarboxylic acid amides and their use as herbicides
DE19502699A1 (de) * 1995-01-28 1996-08-01 Merck Patent Gmbh Arylalkyl-thiadiazinone
WO1998037068A1 (en) 1997-02-21 1998-08-27 Bristol-Myers Squibb Company Benzoic acid derivatives and related compounds as antiarrhythmic agents
DE19929781A1 (de) * 1999-06-29 2001-01-04 Bayer Ag N-[4-(6-Oxotetrahydrotriazinyl)phenyl]amide und ihre Verwendung
RU2008123384A (ru) 2005-11-16 2009-12-27 Новартис АГ (CH) БИОМАРКЕРЫ ДЛЯ ЛЕЧЕНИЯ АНТИТЕЛОМ к Nogo-A ПРИ ПОВРЕЖДЕНИЯХ СПИННОГО МОЗГА
WO2011093401A1 (ja) * 2010-01-27 2011-08-04 三菱レイヨン株式会社 新規連鎖移動剤及びそれを用いた乳化重合
WO2019025554A1 (en) 2017-08-04 2019-02-07 Bayer Aktiengesellschaft 6-PHENYL-4,5-DIHYDROPYRIDAZIN-3 (2H) -ONE DERIVATIVES AS INHIBITORS OF PDE3A AND PDE3B FOR THE TREATMENT OF CANCER
JOP20200024A1 (ar) 2017-08-04 2020-02-02 Bayer Ag مركبات ثنائي هيدروكساديازينون
JP7582953B2 (ja) 2019-02-01 2024-11-13 バイエル アクチェンゲゼルシャフト 過剰増殖性疾患を治療するための１，２，４－トリアジン－３（２ｈ）－オン化合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3314455A (en) * 1964-07-24 1967-04-18 Black Clawson Co Band saw resawing machine
US3377345A (en) * 1966-09-23 1968-04-09 Dow Chemical Co Substituted 3, 4, 5, 6-tetrahydro-2h-1, 3, 4-oxadiazin-2-one compounds and method ofpreparation thereof
FR8169M (en]) * 1967-05-17 1970-08-31
US3946010A (en) * 1975-04-09 1976-03-23 E. R. Squibb & Sons, Inc. 3-Phenyl-2,5-dihydro-as-triazin-6 (1H)-ones
US4097425A (en) * 1975-08-28 1978-06-27 General Electric Company Thermoplastic formable blends, a foaming method and products made thereby
US4097671A (en) * 1975-08-28 1978-06-27 General Electric Company Dihydrooxadiazinones and method for making
US4105848A (en) * 1976-12-27 1978-08-08 General Electric Company Process for the production of dihydrooxadiazinone compounds
ZA827641B (en) * 1981-11-12 1983-09-28 Ici Plc Thiadiazine, oxadiazine and triazine derivatives which possess cardiotonic and/or antihypertensive activity
US4489074A (en) * 1982-11-12 1984-12-18 Imperial Chemical Industries, Plc 1,3,4-Thiadiazin-2-ones
JPH072947B2 (ja) * 1985-06-27 1995-01-18 松下電子工業株式会社 螢光体

Also Published As

Publication number Publication date
DE3172252D1 (en) 1985-10-17
ES507126A0 (es) 1983-07-01
JPS6236370A (ja) 1987-02-17
US4587246A (en) 1986-05-06
NO813850L (no) 1982-05-18
DK498881A (da) 1982-05-15
ES8307231A1 (es) 1983-07-01
AU7709181A (en) 1982-05-20
US4503054A (en) 1985-03-05
ES516588A0 (es) 1983-11-16
ES8401044A1 (es) 1983-11-16
HU185979B (en) 1985-04-28
FI813566A7 (fi) 1982-05-15
ZA817597B (en) 1982-10-27
EP0052442A1 (en) 1982-05-26
ZW26381A1 (en) 1983-06-01
GR79554B (en]) 1984-10-30
DD202020A5 (de) 1983-08-24
US4683232A (en) 1987-07-28
EP0052442B1 (en) 1985-09-11
US4423045A (en) 1983-12-27
PT73995A (en) 1981-12-01
JPS57109771A (en) 1982-07-08
JPS6230771A (ja) 1987-02-09
PL233809A1 (en) 1983-09-12
KR830007624A (ko) 1983-11-04
PT73995B (en) 1983-06-20
NZ198967A (en) 1984-12-14
CA1176250A (en) 1984-10-16
FI813566L (fi) 1982-05-15
MW4881A1 (en) 1983-09-14
PL238802A1 (en) 1983-09-12

Similar Documents

Publication Publication Date Title
JPH0572384B2 (en])
HU184966B (en) Process for producing phenyl-piperazine derivatives of anti-agression activity
JP2001508811A (ja) ｃＧＭＰ−ホスホジエステラーゼ阻害剤としてのアントラニル酸誘導体
EP0085227A1 (en) Thiadiazine derivatives, and pharmaceutical compositions containing them
JPS5890567A (ja) ヘテロ環式化合物、その製法および該化合物を含有する、強心および／または抗高血圧作用を有する製薬組成物
EP0096517A2 (en) Aryl pyrazinones
US3846470A (en) Derivatives of 3-benzoyl-2-({62 -hydroxyphenethylamino)-propionitrile
US6051588A (en) Nitroso esters of β-oxo-amides and aryl propionic acid derivatives of non-steroidal antiinflammatory drugs
US4493835A (en) 1,3,4-Thiadiazines
US4129656A (en) Thiazolidine derivatives, salidiuretic compositions and methods of effecting salidiuresis employing them
DE69405815T2 (de) Acylharnstoffe
JPH0649047A (ja) フェニルカルボキサミドイソオキサゾールの新誘導体及びそれらの塩類、それらの製造法及びこの製造法の新規な中間体、それらの薬剤としての用途並びにそれらを含有する製薬組成物
US4457872A (en) 2-Hydroxyoxanilic acid derivatives
US4654369A (en) Esters of 2-(substituted sulfamyl)-6-nitro-benzoic acid and pharmaceutical compositions
JPS6310777A (ja) ピペラジンアセトアミド誘導体
PT869952E (pt) Derivados de 5-naftalen-1-il-1,3-dioxanos processo para a sua preparacao e sua aplicacao em terapeutica
JPH0124793B2 (en])
US3183255A (en) Esters of diphenyl acetohydroxamic and alpha-hydroxy-diphenyl acetohydroxamic acids aith tertiary amino alcohols
JPH0437073B2 (en])
JPH0519543B2 (en])
JPS6153256A (ja) アルカイン誘導体
BE654017A (en])
Hokfelt et al. Hypoglycemic Activity in Relation to Chemical Structure of Potential Oral Antidiabetic Substances. II. Analogs of 1-Sulfonyl-3-alkylureas
JPS62149655A (ja) ハロアセチル尿素誘導体
AT267518B (de) Verfahren zur Herstellung von neuen α-(3-Indolyl)-essigsäuren und ihren Salzen